Search Results for: Alzheimer

3183 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
PTGIS and APP prostaglandin I2 (prostacyclin) synthase amyloid beta (A4) precursor protein
  • Metabolism of vitamins and cofactors
  • Bile acid and bile salt metabolism
  • Defective CD320 causes methylmalonic aciduria
  • Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF
  • Metabolism of lipids and lipoproteins
  • Defective BTD causes biotidinase deficiency
  • Metabolic disorders of biological oxidation enzymes
  • Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE
  • Arachidonic acid metabolism
  • Defective AMN causes hereditary megaloblastic anemia 1
  • Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
  • Endogenous sterols
  • Synthesis of bile acids and bile salts
  • Synthesis of bile acids and bile salts via 24-hydroxycholesterol
  • Defective GIF causes intrinsic factor deficiency
  • Defective FMO3 causes Trimethylaminuria (TMAU)
  • Defective HLCS causes multiple carboxylase deficiency
  • Defective MMAB causes methylmalonic aciduria type cblB
  • Eicosanoids
  • Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
  • Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
  • Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
  • Defective MMAA causes methylmalonic aciduria type cblA
  • Defective CUBN causes hereditary megaloblastic anemia 1
  • Synthesis of bile acids and bile salts via 27-hydroxycholesterol
  • Defective MAOA causes Brunner syndrome (BRUNS)
  • Defects in biotin (Btn) metabolism
  • Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
  • Defective TCN2 causes hereditary megaloblastic anemia
  • Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
  • Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC
  • Defective MTR causes methylmalonic aciduria and homocystinuria type cblG
  • Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
  • Phase 1 - Functionalization of compounds
  • Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
  • Cytochrome P450 - arranged by substrate type
  • Nicotinamide salvaging
  • Biological oxidations
  • Sterols are 12-hydroxylated by CYP8B1
  • Defects in cobalamin (B12) metabolism
  • Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
  • Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
  • Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
  • Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
  • Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD
  • Defective CYP1B1 causes Glaucoma
  • Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
  • Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
  • Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
  • Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
  • Defective MUT causes methylmalonic aciduria mut type
  • Metabolism of water-soluble vitamins and cofactors
  • Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
  • Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
  • Nicotinate metabolism
  • Defects in vitamin and cofactor metabolism
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
  • Phenylbutazone
  • Epoprostenol
  • (6E)-7-{6-[(1E)-OCT-1-ENYL]-2,3-DIAZABICYCLO[2.2.1]HEPT-2-EN-5-YL}HEPT-6-ENOIC ACID
SHMT2 and APP serine hydroxymethyltransferase 2 (mitochondrial) amyloid beta (A4) precursor protein
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
  • Pyridoxal Phosphate
  • Tetrahydrofolic acid
  • Glycine
SLC7A1 and APP solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 amyloid beta (A4) precursor protein
  • Transport of inorganic cations/anions and amino acids/oligopeptides
  • Amino acid transport across the plasma membrane
  • SLC-mediated transmembrane transport
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
  • L-Lysine
  • L-Arginine
  • L-Ornithine
WARS and APP tryptophanyl-tRNA synthetase amyloid beta (A4) precursor protein
  • Cytosolic tRNA aminoacylation
  • tRNA Aminoacylation
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
  • L-Tryptophan
  • Tryptophanyl-5\'amp
  • L-Tryptophanamide
NMNAT1 and APP nicotinamide nucleotide adenylyltransferase 1 amyloid beta (A4) precursor protein
  • Metabolism of vitamins and cofactors
  • Defective GIF causes intrinsic factor deficiency
  • Defective CD320 causes methylmalonic aciduria
  • Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF
  • Defective HLCS causes multiple carboxylase deficiency
  • Defective MMAB causes methylmalonic aciduria type cblB
  • Defective BTD causes biotidinase deficiency
  • Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC
  • Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD
  • Defective MTR causes methylmalonic aciduria and homocystinuria type cblG
  • Defective MMAA causes methylmalonic aciduria type cblA
  • Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE
  • Defective CUBN causes hereditary megaloblastic anemia 1
  • Defective AMN causes hereditary megaloblastic anemia 1
  • Defective MUT causes methylmalonic aciduria mut type
  • Metabolism of water-soluble vitamins and cofactors
  • Defects in biotin (Btn) metabolism
  • Defective TCN2 causes hereditary megaloblastic anemia
  • Nicotinate metabolism
  • Defects in vitamin and cofactor metabolism
  • Defects in cobalamin (B12) metabolism
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
  • Nicotinamide-Adenine-Dinucleotide
  • Nicotinamide Mononucleotide
  • Deamido-Nad+
POMC and APP proopiomelanocortin amyloid beta (A4) precursor protein
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
  • Metabolism of lipids and lipoproteins
  • G alpha (s) signalling events
  • Glucocorticoid biosynthesis
  • Class A/1 (Rhodopsin-like receptors)
  • Metabolic disorders of biological oxidation enzymes
  • Androgen biosynthesis
  • Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
  • Phase 1 - Functionalization of compounds
  • Peptide hormone metabolism
  • Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
  • Peptide ligand-binding receptors
  • Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
  • Cytochrome P450 - arranged by substrate type
  • Endogenous sterols
  • Peptide hormone biosynthesis
  • G alpha (i) signalling events
  • Biological oxidations
  • Defective FMO3 causes Trimethylaminuria (TMAU)
  • Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
  • Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
  • Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
  • Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
  • Opioid Signalling
  • Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
  • GPCR ligand binding
  • Defective CYP1B1 causes Glaucoma
  • Metabolism of steroid hormones and vitamin D
  • Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
  • Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
  • Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
  • Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
  • GPCR downstream signaling
  • Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
  • G-protein activation
  • Defective MAOA causes Brunner syndrome (BRUNS)
  • Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
  • Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
  • Loperamide
  • Etorphine
  • Dihydromorphine
JUN and BCL3 jun proto-oncogene B-cell CLL/lymphoma 3
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Cellular Senescence
  • FCERI mediated MAPK activation
  • Toll Like Receptor TLR6:TLR2 Cascade
  • Activated TLR4 signalling
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Activation of the AP-1 family of transcription factors
  • MyD88 cascade initiated on plasma membrane
  • Toll Like Receptor 5 (TLR5) Cascade
  • Pre-NOTCH Transcription and Translation
  • MyD88 dependent cascade initiated on endosome
  • Pre-NOTCH Expression and Processing
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • MyD88:Mal cascade initiated on plasma membrane
  • Toll Like Receptor 9 (TLR9) Cascade
  • Innate Immune System
  • Signaling by NOTCH
  • TRIF-mediated TLR3/TLR4 signaling
  • MAP kinase activation in TLR cascade
  • Senescence-Associated Secretory Phenotype (SASP)
  • MyD88-independent cascade
  • Toll Like Receptor 2 (TLR2) Cascade
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • Oxidative Stress Induced Senescence
  • Toll Like Receptor 3 (TLR3) Cascade
  • Toll Like Receptor 4 (TLR4) Cascade
  • Fc epsilon receptor (FCERI) signaling
  • MAPK targets/ Nuclear events mediated by MAP kinases
  • Vinblastine
  • Irbesartan
  • Arsenic trioxide
NFKB1 and BCL3 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 B-cell CLL/lymphoma 3
  • Signaling by the B Cell Receptor (BCR)
  • NF-kB is activated and signals survival
  • Downstream TCR signaling
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Cellular Senescence
  • RIP-mediated NFkB activation via ZBP1
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Downstream signaling events of B Cell Receptor (BCR)
  • FCERI mediated NF-kB activation
  • MyD88 cascade initiated on plasma membrane
  • Toll Like Receptor 5 (TLR5) Cascade
  • ZBP1(DAI) mediated induction of type I IFNs
  • p75NTR signals via NF-kB
  • Transcriptional regulation of white adipocyte differentiation
  • MyD88 dependent cascade initiated on endosome
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • MyD88:Mal cascade initiated on plasma membrane
  • Toll Like Receptor 9 (TLR9) Cascade
  • Innate Immune System
  • Regulated proteolysis of p75NTR
  • Signalling by NGF
  • TRIF-mediated TLR3/TLR4 signaling
  • Cytosolic sensors of pathogen-associated DNA
  • Senescence-Associated Secretory Phenotype (SASP)
  • Cytokine Signaling in Immune system
  • p75 NTR receptor-mediated signalling
  • MyD88-independent cascade
  • Toll Like Receptor 2 (TLR2) Cascade
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Signaling by Interleukins
  • TCR signaling
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • Interleukin-1 processing
  • Toll Like Receptor 3 (TLR3) Cascade
  • Toll Like Receptor 4 (TLR4) Cascade
  • Activation of NF-kappaB in B cells
  • Fc epsilon receptor (FCERI) signaling
  • TRAF6 mediated NF-kB activation
  • Interleukin-1 signaling
  • Adaptive Immune System
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Thalidomide
  • Pranlukast
  • Triflusal
EPHA2 and EFNA5 EPH receptor A2 ephrin-A5
  • EPHA-mediated growth cone collapse
  • EPH-ephrin mediated repulsion of cells
  • Axon guidance
  • EPH-Ephrin signaling
  • EPHA-mediated growth cone collapse
  • EPH-ephrin mediated repulsion of cells
  • Axon guidance
  • EPH-Ephrin signaling
  • Dasatinib
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Regorafenib
GLP1R and TSPAN13 glucagon-like peptide 1 receptor tetraspanin 13
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • GPCR downstream signaling
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Integration of energy metabolism
  • G alpha (s) signalling events
  • Regulation of insulin secretion
  • Glucagon-type ligand receptors
  • Metabolic disorders of biological oxidation enzymes
  • GPCR ligand binding
  • Class B/2 (Secretin family receptors)
  • Glucagon recombinant
  • Exenatide
  • Liraglutide
PGGT1B and RRAS2 protein geranylgeranyltransferase type I, beta subunit related RAS viral (r-ras) oncogene homolog 2
  • 4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE
  • GERANYLGERANYL DIPHOSPHATE
  • 2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE
PRKAA1 and STK11 protein kinase, AMP-activated, alpha 1 catalytic subunit serine/threonine kinase 11
  • Insulin receptor signalling cascade
  • Regulation of AMPK activity via LKB1
  • IRS-mediated signalling
  • Regulation of Rheb GTPase activity by AMPK
  • mTOR signalling
  • IRS-related events
  • mTOR signalling
  • IGF1R signaling cascade
  • IRS-related events triggered by IGF1R
  • IRS-mediated signalling
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • Energy dependent regulation of mTOR by LKB1-AMPK
  • PKB-mediated events
  • PI3K Cascade
  • PKB-mediated events
  • PI3K Cascade
  • Signaling by Insulin receptor
  • Insulin receptor signalling cascade
  • Integration of energy metabolism
  • IRS-mediated signalling
  • Regulation of AMPK activity via LKB1
  • mTOR signalling
  • IRS-related events
  • mTOR signalling
  • IGF1R signaling cascade
  • IRS-related events triggered by IGF1R
  • IRS-mediated signalling
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • Energy dependent regulation of mTOR by LKB1-AMPK
  • AMPK inhibits chREBP transcriptional activation activity
  • PKB-mediated events
  • PI3K Cascade
  • PKB-mediated events
  • PI3K Cascade
  • Signaling by Insulin receptor
  • Adenosine monophosphate
  • Adenosine triphosphate
  • Phenformin
TUBA1B and PSEN1 tubulin, alpha 1b presenilin 1
  • Transport of connexons to the plasma membrane
  • Mitotic Prometaphase
  • Organelle biogenesis and maintenance
  • Axon guidance
  • Hedgehog 'off' state
  • Separation of Sister Chromatids
  • Translocation of GLUT4 to the plasma membrane
  • G2/M Transition
  • L1CAM interactions
  • Mitotic Anaphase
  • Recycling pathway of L1
  • Recruitment of NuMA to mitotic centrosomes
  • Formation of tubulin folding intermediates by CCT/TriC
  • Intraflagellar transport
  • M Phase
  • Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding
  • Post-chaperonin tubulin folding pathway
  • Gap junction trafficking and regulation
  • MHC class II antigen presentation
  • Recruitment of mitotic centrosome proteins and complexes
  • Protein folding
  • Gap junction assembly
  • Gap junction trafficking
  • Kinesins
  • Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
  • Assembly of the primary cilium
  • Factors involved in megakaryocyte development and platelet production
  • Cell Cycle, Mitotic
  • Resolution of Sister Chromatid Cohesion
  • Chaperonin-mediated protein folding
  • Signaling by Hedgehog
  • Centrosome maturation
  • Mitotic G2-G2/M phases
  • Mitotic Metaphase and Anaphase
  • Adaptive Immune System
  • Degradation of the extracellular matrix
  • Epothilone D
  • Epothilone B
  • 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE
RAF1 and RRAS2 Raf-1 proto-oncogene, serine/threonine kinase related RAS viral (r-ras) oncogene homolog 2
  • Signaling by GPCR
  • Signaling by FGFR in disease
  • MEK activation
  • FCERI mediated MAPK activation
  • CREB phosphorylation through the activation of Ras
  • Signaling by EGFRvIII in Cancer
  • SHC1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • DAP12 signaling
  • Rap1 signalling
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • SOS-mediated signalling
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • SHC-mediated signalling
  • Signaling by PDGF
  • DAP12 interactions
  • SHC-related events triggered by IGF1R
  • GRB2 events in EGFR signaling
  • Signaling by ERBB4
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by Interleukins
  • SHC1 events in ERBB4 signaling
  • GP1b-IX-V activation signalling
  • Signaling by VEGF
  • Signalling to RAS
  • Downstream signal transduction
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Interleukin-2 signaling
  • Platelet activation, signaling and aggregation
  • Frs2-mediated activation
  • Transmission across Chemical Synapses
  • Adaptive Immune System
  • Signaling by Leptin
  • Signalling to ERKs
  • Prolonged ERK activation events
  • Axon guidance
  • IRS-mediated signalling
  • IGF1R signaling cascade
  • VEGFA-VEGFR2 Pathway
  • IRS-related events triggered by IGF1R
  • Ion channel transport
  • GRB2 events in ERBB2 signaling
  • VEGFR2 mediated cell proliferation
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • RAF phosphorylates MEK
  • Downstream signaling of activated FGFR
  • Stimuli-sensing channels
  • NCAM signaling for neurite out-growth
  • RAF/MAP kinase cascade
  • Signalling to p38 via RIT and RIN
  • Post NMDA receptor activation events
  • Innate Immune System
  • Signaling by Insulin receptor
  • Signalling by NGF
  • Insulin receptor signalling cascade
  • SOS-mediated signalling
  • SHC-mediated signalling
  • Cytokine Signaling in Immune system
  • IRS-related events
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • SHC-related events
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by FGFR
  • ARMS-mediated activation
  • RAF activation
  • SHC1 events in EGFR signaling
  • IRS-mediated signalling
  • FRS2-mediated cascade
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • Sorafenib
  • Regorafenib
  • Dabrafenib
APOE and LDLR apolipoprotein E low density lipoprotein receptor
  • Lipoprotein metabolism
  • Metabolism of lipids and lipoproteins
  • Chylomicron-mediated lipid transport
  • Lipid digestion, mobilization, and transport
  • Diseases associated with visual transduction
  • HDL-mediated lipid transport
  • Visual phototransduction
  • Scavenging by Class A Receptors
  • Retinoid metabolism and transport
  • Lipoprotein metabolism
  • LDL-mediated lipid transport
  • Visual phototransduction
  • Metabolism of lipids and lipoproteins
  • Chylomicron-mediated lipid transport
  • Lipid digestion, mobilization, and transport
  • Diseases associated with visual transduction
  • Retinoid metabolism and transport
  • Human Serum Albumin
  • Serum albumin iodonated
  • Porfimer
  • Alpha-D-Mannose
APOE and GCDH apolipoprotein E glutaryl-CoA dehydrogenase
  • Lipoprotein metabolism
  • Metabolism of lipids and lipoproteins
  • Chylomicron-mediated lipid transport
  • Lipid digestion, mobilization, and transport
  • Diseases associated with visual transduction
  • HDL-mediated lipid transport
  • Visual phototransduction
  • Scavenging by Class A Receptors
  • Retinoid metabolism and transport
  • Lysine catabolism
  • Metabolism of amino acids and derivatives
  • Human Serum Albumin
  • Serum albumin iodonated
  • Flavin-Adenine Dinucleotide
  • S-4-Nitrobutyryl-Coa
APOE and PRDX2 apolipoprotein E peroxiredoxin 2
  • Lipoprotein metabolism
  • Metabolism of lipids and lipoproteins
  • Chylomicron-mediated lipid transport
  • Lipid digestion, mobilization, and transport
  • Diseases associated with visual transduction
  • HDL-mediated lipid transport
  • Visual phototransduction
  • Scavenging by Class A Receptors
  • Retinoid metabolism and transport
  • Detoxification of Reactive Oxygen Species
  • Human Serum Albumin
  • Serum albumin iodonated
  • 3-Sulfinoalanine
  • N-Carbamoyl-Alanine
FYN and PIK3R1 FYN proto-oncogene, Src family tyrosine kinase phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by FGFR in disease
  • DCC mediated attractive signaling
  • Netrin mediated repulsion signals
  • Signaling by EGFRvIII in Cancer
  • Nef and signal transduction
  • Signaling by SCF-KIT
  • DAP12 signaling
  • Downstream signaling events of B Cell Receptor (BCR)
  • Regulation of KIT signaling
  • PI3K/AKT activation
  • PI-3K cascade
  • EPH-Ephrin signaling
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • FCGR activation
  • Signaling by PDGF
  • DAP12 interactions
  • GAB1 signalosome
  • Host Interactions of HIV factors
  • CD28 co-stimulation
  • CD28 dependent PI3K/Akt signaling
  • The role of Nef in HIV-1 replication and disease pathogenesis
  • Signaling by ERBB4
  • Constitutive PI3K/AKT Signaling in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • PI3K events in ERBB4 signaling
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by Interleukins
  • Signaling by VEGF
  • Downstream signal transduction
  • Sema3A PAK dependent Axon repulsion
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Nephrin interactions
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • CRMPs in Sema3A signaling
  • PI3K/AKT Signaling in Cancer
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Adaptive Immune System
  • Platelet Adhesion to exposed collagen
  • Axon guidance
  • Costimulation by the CD28 family
  • PIP3 activates AKT signaling
  • HIV Infection
  • VEGFA-VEGFR2 Pathway
  • EPHB-mediated forward signaling
  • EPHA-mediated growth cone collapse
  • Ephrin signaling
  • EPH-ephrin mediated repulsion of cells
  • PI3K events in ERBB2 signaling
  • Regulation of signaling by CBL
  • Downstream signaling of activated FGFR
  • NCAM signaling for neurite out-growth
  • Netrin-1 signaling
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • Signalling by NGF
  • Semaphorin interactions
  • CTLA4 inhibitory signaling
  • Cytokine Signaling in Immune system
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • PECAM1 interactions
  • CD28 dependent Vav1 pathway
  • Signaling by FGFR
  • Cell surface interactions at the vascular wall
  • GPVI-mediated activation cascade
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Metabolism of lipids and lipoproteins
  • Signaling by FGFR in disease
  • Signaling by EGFRvIII in Cancer
  • Signaling by SCF-KIT
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Interleukin receptor SHC signaling
  • PI-3K cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Signaling by FGFR1 mutants
  • Interleukin-7 signaling
  • Role of phospholipids in phagocytosis
  • Phospholipid metabolism
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • PI3K Cascade
  • Signaling by PDGF
  • DAP12 interactions
  • GAB1 signalosome
  • G-protein beta:gamma signalling
  • CD28 co-stimulation
  • CD28 dependent PI3K/Akt signaling
  • Signaling by ERBB4
  • Constitutive PI3K/AKT Signaling in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • PI3K events in ERBB4 signaling
  • G alpha (q) signalling events
  • Signaling by ERBB2
  • Signaling by EGFR
  • GPCR downstream signaling
  • Signaling by Interleukins
  • TCR signaling
  • Signaling by VEGF
  • GP1b-IX-V activation signalling
  • Downstream signal transduction
  • Signaling by FGFR mutants
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Nephrin interactions
  • Interleukin-2 signaling
  • PI3K/AKT Signaling in Cancer
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Adaptive Immune System
  • G alpha (q) signalling events
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • IRS-mediated signalling
  • PIP3 activates AKT signaling
  • IGF1R signaling cascade
  • VEGFA-VEGFR2 Pathway
  • Synthesis of PIPs at the plasma membrane
  • IRS-related events triggered by IGF1R
  • G beta:gamma signalling through PI3Kgamma
  • PI3K events in ERBB2 signaling
  • Regulation of signaling by CBL
  • Downstream signaling of activated FGFR
  • G alpha (12/13) signalling events
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • PI Metabolism
  • Innate Immune System
  • Signaling by Insulin receptor
  • Signalling by NGF
  • Insulin receptor signalling cascade
  • Cytokine Signaling in Immune system
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • IRS-related events
  • NGF signalling via TRKA from the plasma membrane
  • Tie2 Signaling
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Cell surface interactions at the vascular wall
  • Signaling by FGFR
  • IRS-mediated signalling
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • GPVI-mediated activation cascade
  • Interleukin receptor SHC signaling
  • Signaling by FGFR1 fusion mutants
  • Constitutive Signaling by EGFRvIII
  • PI3K Cascade
  • Dasatinib
  • 1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane
  • Isoproterenol
  • (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE
GHR and PIK3R1 growth hormone receptor phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
  • Nuclear signaling by ERBB4
  • Cytokine Signaling in Immune system
  • Signaling by ERBB4
  • Prolactin receptor signaling
  • Growth hormone receptor signaling
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Metabolism of lipids and lipoproteins
  • Signaling by FGFR in disease
  • Signaling by EGFRvIII in Cancer
  • Signaling by SCF-KIT
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Interleukin receptor SHC signaling
  • PI-3K cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Signaling by FGFR1 mutants
  • Interleukin-7 signaling
  • Role of phospholipids in phagocytosis
  • Phospholipid metabolism
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • PI3K Cascade
  • Signaling by PDGF
  • DAP12 interactions
  • GAB1 signalosome
  • G-protein beta:gamma signalling
  • CD28 co-stimulation
  • CD28 dependent PI3K/Akt signaling
  • Signaling by ERBB4
  • Constitutive PI3K/AKT Signaling in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • PI3K events in ERBB4 signaling
  • G alpha (q) signalling events
  • Signaling by ERBB2
  • Signaling by EGFR
  • GPCR downstream signaling
  • Signaling by Interleukins
  • TCR signaling
  • Signaling by VEGF
  • GP1b-IX-V activation signalling
  • Downstream signal transduction
  • Signaling by FGFR mutants
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Nephrin interactions
  • Interleukin-2 signaling
  • PI3K/AKT Signaling in Cancer
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Adaptive Immune System
  • G alpha (q) signalling events
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • IRS-mediated signalling
  • PIP3 activates AKT signaling
  • IGF1R signaling cascade
  • VEGFA-VEGFR2 Pathway
  • Synthesis of PIPs at the plasma membrane
  • IRS-related events triggered by IGF1R
  • G beta:gamma signalling through PI3Kgamma
  • PI3K events in ERBB2 signaling
  • Regulation of signaling by CBL
  • Downstream signaling of activated FGFR
  • G alpha (12/13) signalling events
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • PI Metabolism
  • Innate Immune System
  • Signaling by Insulin receptor
  • Signalling by NGF
  • Insulin receptor signalling cascade
  • Cytokine Signaling in Immune system
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • IRS-related events
  • NGF signalling via TRKA from the plasma membrane
  • Tie2 Signaling
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Cell surface interactions at the vascular wall
  • Signaling by FGFR
  • IRS-mediated signalling
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • GPVI-mediated activation cascade
  • Interleukin receptor SHC signaling
  • Signaling by FGFR1 fusion mutants
  • Constitutive Signaling by EGFRvIII
  • PI3K Cascade
  • Somatropin recombinant
  • Pegvisomant
  • Isoproterenol
  • (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE
GRB2 and PIK3R1 growth factor receptor-bound protein 2 phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Metabolism of lipids and lipoproteins
  • Signaling by FGFR in disease
  • Signaling by EGFRvIII in Cancer
  • Signaling by SCF-KIT
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Interleukin receptor SHC signaling
  • PI-3K cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Signaling by FGFR1 mutants
  • Interleukin-7 signaling
  • Role of phospholipids in phagocytosis
  • Phospholipid metabolism
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • PI3K Cascade
  • Signaling by PDGF
  • DAP12 interactions
  • GAB1 signalosome
  • G-protein beta:gamma signalling
  • CD28 co-stimulation
  • CD28 dependent PI3K/Akt signaling
  • Signaling by ERBB4
  • Constitutive PI3K/AKT Signaling in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • PI3K events in ERBB4 signaling
  • G alpha (q) signalling events
  • Signaling by ERBB2
  • Signaling by EGFR
  • GPCR downstream signaling
  • Signaling by Interleukins
  • TCR signaling
  • Signaling by VEGF
  • GP1b-IX-V activation signalling
  • Downstream signal transduction
  • Signaling by FGFR mutants
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Nephrin interactions
  • Interleukin-2 signaling
  • PI3K/AKT Signaling in Cancer
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Adaptive Immune System
  • G alpha (q) signalling events
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • IRS-mediated signalling
  • PIP3 activates AKT signaling
  • IGF1R signaling cascade
  • VEGFA-VEGFR2 Pathway
  • Synthesis of PIPs at the plasma membrane
  • IRS-related events triggered by IGF1R
  • G beta:gamma signalling through PI3Kgamma
  • PI3K events in ERBB2 signaling
  • Regulation of signaling by CBL
  • Downstream signaling of activated FGFR
  • G alpha (12/13) signalling events
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • PI Metabolism
  • Innate Immune System
  • Signaling by Insulin receptor
  • Signalling by NGF
  • Insulin receptor signalling cascade
  • Cytokine Signaling in Immune system
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • IRS-related events
  • NGF signalling via TRKA from the plasma membrane
  • Tie2 Signaling
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Cell surface interactions at the vascular wall
  • Signaling by FGFR
  • IRS-mediated signalling
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • GPVI-mediated activation cascade
  • Interleukin receptor SHC signaling
  • Signaling by FGFR1 fusion mutants
  • Constitutive Signaling by EGFRvIII
  • PI3K Cascade
  • Pegademase bovine
  • 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
  • Isoproterenol
  • (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE

Page 11 out of 160 pages